ALNYLAM PHARMACEUTICALS INC (ALNY)

US02043Q1076 - Common Stock

143.8  -2.27 (-1.55%)

After market: 143.8 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.83B1.04B844.30M492.90M219.80M
Cost Of Goods
310.41M168.80M140.10M78.10M25.10M
Gross Profit
1.52B868.60M704.10M414.80M194.70M
Operating Expenses
1.80B1.65B1.41B1.24B1.13B
Research and Development
1.00B883.00M792.20M654.80M655.10M
Selling, General, and Administrative Expenses
795.65M770.70M620.60M588.40M479.00M
Operating Income
-282.18M-785.10M-708.70M-828.40M-939.40M
Interest Income/Expense
-133.60M-259.10M-124.20M-72.70M33.40M
Other Income/Expense
-17.74M-6.20M-19.30M45.50M20.70M
Non Recurring Items
0.00-76.60MN/AN/A0.00
Income Before Taxes
-433.52M-1.13B-852.10M-855.60M-885.30M
Income Tax
6.72M4.20M700.00K2.70M900.00K
Net Income
-440.24M-1.13B-852.80M-858.30M-886.10M
EBITDA
-228.12M-740.60M-661.10M-793.60M-922.20M
 
Per Share Data
EPS Diluted Total Ops
-3.52-9.30-7.20-7.46-8.11
Non GAAP EPS
-3.56-8.66-7.12-7.66-8.15
 
Statistics
Gross Profit Margin
83.02%83.73%83.39%84.16%88.58%
Profit Margin
-24.08%-109.04%-101.01%-174.13%-403.14%
Operating Profit Margin
-15.43%-75.68%-83.94%-168.07%-427.39%

All data in USD

Charts